| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,279,000 | 2,195,000 | 2,049,000 | 2,048,000 | | Cost of Revenue | 975,000 | (173,000) | 2,042,000 | 911,000 | | | Gross Profit | 1,304,000 | 2,368,000 | 7,000 | 1,137,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 872,000 | 2,003,000 | (305,000) | 833,000 | | Non Recurring | 6,000 | (456,000) | 462,000 | 5,000 | | Others | 253,000 | 728,000 | (212,000) | 245,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 173,000 | 93,000 | 62,000 | 54,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 136,000 |
-
| 152,000 | 4,000 | | Earnings Before Interest And Taxes | 309,000 | 90,000 | 212,000 | 58,000 | | Interest Expense | 110,000 | 106,000 | 106,000 | 102,000 | | Income Before Tax | 199,000 | (16,000) | 106,000 | (44,000) | | Income Tax Expense | 5,000 | (6,000) | (5,000) | (15,000) | | Minority Interest |
-
| (3,000) | (2,000) |
-
| | | | Net Income From Continuing Ops | 194,000 | (10,000) | 111,000 | (29,000) | | | Non-recurring Events | | Discontinued Operations | (11,000) | (23,000) | (7,000) | 14,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 183,000 | (33,000) | 104,000 | (15,000) | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $178,000 | ($33,000) | $104,000 | ($15,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
